SoFi CEO Anthony Noto calls the Powell Fed era a mixed bag, praising the ultimate economic stability despite policy stumbles. As the baton passes to a new Treasury Secretary, investors weigh SoFi's record growth against a cautious 2026 outlook.
In the quarters leading to his retirement as CEO, Warren Buffett orchestrated a significant portfolio shift, slashing Berkshire's stake in Bank of America while steadily accumulating shares in Domino's Pizza, highlighting a strategic bet on consumer resilience and brand loyalty.
Altria Group names CFO Salvatore Mancuso as its incoming CEO, accelerating its smoke-free transition while taking a massive impairment charge on past investments, signaling a sharp strategic reassessment.
The Walt Disney Company exceeded Wall Street expectations in its fiscal first quarter, delivering robust results across its entertainment, experiences, and streaming divisions as longtime CEO Bob Iger prepares to hand over the reins later this year.
The Walt Disney Company's board is reportedly finalizing its choice for the next chief executive, with Josh D’Amaro, the chairman of its highly profitable parks and experiences division, poised to take the helm. The decision would conclude a lengthy succession search and mark a pivotal leadership transition for the global entertainment giant.
Disney's iconic leader, who returned to steady the company in 2022, is reportedly preparing to exit the CEO role ahead of his contract's expiration, setting the stage for a high-stakes succession search.
Disney's board is set to convene next week to vote on a successor for CEO Bob Iger, who is now expected to depart before his contract ends in 2026, aiming to give his replacement a 'fresh start'.
Peter McGuinness, the CEO who sought to reposition plant-based meat for mainstream consumers by moving beyond climate messaging, is departing Impossible Foods. His exit comes as the broader alternative protein sector faces significant sales declines and strategic recalibration.
In a recent interview, Robinhood CEO Vlad Tenev argues that artificial intelligence will likely reshape the workforce by creating new, unforeseen categories of employment, drawing parallels to past technological revolutions. However, he acknowledges the unprecedented speed of AI-driven change is a cause for concern.
Eli Lilly's CEO sees Medicare's new policy covering obesity treatments as a pivotal moment, poised to unlock access for millions of beneficiaries to its incoming oral drug, orforglipron, and intensify the market battle with Novo Nordisk.
Facing internal resistance to AI adoption, payments company MassPay linked its use directly to a profit-sharing pool. The result, according to CEO Ran Grushkowsky, was not just significant cost savings and eliminated hiring needs, but a notable boost in team morale.
ABIVAX (NASDAQ:ABVX) shares have skyrocketed over 2000% in recent months, fueled by speculation of an Eli Lilly buyout and promising clinical data for its lead drug. CEO Marc De Garidel has publicly dismissed the acquisition rumors as 'noise,' redirecting focus to the company's financing needs and advancing therapeutic programs.
While CeoTronics AG's (FRA:CEK) recent earnings report failed to ignite its stock price, a deeper look reveals a robust cash conversion story that may please long-term shareholders and point to healthier fundamentals than the headline profit figure suggests.
Nvidia is set to make a landmark investment in OpenAI's latest funding round, CEO Jensen Huang confirmed, signaling a deepening alliance between the AI hardware giant and the leading AI research lab. However, reports of internal skepticism at Nvidia introduce uncertainty into the final terms and timing of the deal.
GameStop's stock jumped nearly 5% Friday after the company announced plans for a billion-dollar acquisition, described by CEO Ryan Cohen as a potentially 'transformational' move for the retailer and the markets.
Five years after its meme-stock frenzy, GameStop is aiming for a colossal acquisition to transform its business. CEO Ryan Cohen could earn a $35 billion payday if he succeeds in reaching a $100 billion market cap—a goal experts call wildly ambitious.
After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.
CEO Brian Niccol says employees' questions about share prices reflect pride and care, as the coffee giant navigates workplace reforms and ongoing labor disputes.
A UK tribunal has allowed a massive lawsuit accusing Valve of anti-competitive practices to proceed, drawing vocal support from Epic Games CEO Tim Sweeney, who calls Steam the last major platform clinging to restrictive payment rules.
CareDx CEO John Hanna sold over 19,000 shares under a pre-arranged trading plan, a move that comes as the transplant diagnostics firm posts strong revenue growth but continues to navigate a challenging stock market environment.
